Literature DB >> 20536845

Potential role of immunosenescence in cancer development.

Tamas Fulop1, Rami Kotb, Carl F Fortin, Graham Pawelec, Flavia de Angelis, Anis Larbi.   

Abstract

The incidence and prevalence of most cancers increase with age. The reasons for this may include tumor escape mechanisms and decreased immunosurveillance, but most are caused by the time required for carcinogenesis, according to most scientists. The immune system is a unique mechanism of defense against pathogens and possibly cancers; however, there is a body of evidence that the immune system of the aged is eroded, a phenomenon termed immunosenescence. There is a growing interest in immunosenescence and how it may contribute to the increased number of cancers with aging. Each arm of the immune system, innate and adaptive, is altered with aging, contributing to increased tumorigenesis. Understanding the contribution of immunosenescence to cancer development and progression may lead to better interventions for the elderly.

Entities:  

Mesh:

Year:  2010        PMID: 20536845     DOI: 10.1111/j.1749-6632.2009.05370.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  61 in total

Review 1.  Epidemiologic perspective on immune-surveillance in cancer.

Authors:  Daniel W Cramer; Olivera J Finn
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  Thymus Size and Age-related Thymic Involution: Early Programming, Sexual Dimorphism, Progenitors and Stroma.

Authors:  Jingang Gui; Lisa Maria Mustachio; Dong-Ming Su; Ruth W Craig
Journal:  Aging Dis       Date:  2012-03-14       Impact factor: 6.745

3.  A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.

Authors:  Doris Lambracht-Washington; Roger N Rosenberg
Journal:  Neurobiol Aging       Date:  2014-12-12       Impact factor: 4.673

Review 4.  Lung cancer, elderly and immune checkpoint inhibitors.

Authors:  Francesca Casaluce; Assunta Sgambato; Paolo Maione; Alessia Spagnuolo; Cesare Gridelli
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.

Authors:  Esther M de Kruijf; Esther Bastiaannet; Francesca Rubertá; Anton J M de Craen; Peter J K Kuppen; Vincent T H B M Smit; Cornelis J H van de Velde; Gerrit Jan Liefers
Journal:  Mol Oncol       Date:  2014-04-08       Impact factor: 6.603

6.  IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice.

Authors:  C Jackaman; D E Dye; D J Nelson
Journal:  Age (Dordr)       Date:  2014-04-19

7.  Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer.

Authors:  Marla Karine Amarante; Karen Brajão de Oliveira; Roberta Losi Guembarovski; Ana Cristina da Silva do Amaral Herrera; Alda Losi Guembarovski; Walter Jorge Sobrinho; Julio Cesar Voltarelli; Maria Angelica Ehara Watanabe
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

8.  The aging immune system and its relationship with cancer.

Authors:  Anthony D Foster; Amogh Sivarapatna; Ronald E Gress
Journal:  Aging health       Date:  2011-10-01

9.  Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes.

Authors:  A S Mansfield; W K Nevala; R S Dronca; A A Leontovich; L Shuster; S N Markovic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 10.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.

Authors:  Tobias R Kollmann; Ofer Levy; Ruth R Montgomery; Stanislas Goriely
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.